Interstitial Photodynamic Therapy during Standard Chemotherapy for Palliation of Patients with Head and Neck Squamous Cell Carcinoma - Phase II
Description: 

Aim 1 is to demonstrate that our image-guided I-PDT dosimetry system can be used to tailor this therapy to individual patients. Aim 2 to investigate correlations among tumor tissue response, in vivo optical light dosimetry, and quantitative spectroscopy measurements.

Study Number: 

I 235613

Phase: 
II
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT02068157

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.